Company Mauna Kea Technologies

Equities

ALMKT

FR0010609263

Advanced Medical Equipment & Technology

Market Closed - Euronext Paris Other stock markets 16:19:52 10/12/2024 GMT			5-day change	1st Jan Change
0.1708 ^EUR	-2.29%		+1.55%	-63.74%

11-19	Mauna Kea: launches a review of its strategic options	CF
10-17	Mauna Kea Technologies Announces New Positive Clinical Results for Cellvizio in Food Intolerance	CI

Business description: Mauna Kea Technologies

Mauna Kea Technologies specializes in designing, developing, and selling optical biopsy devices and tools. The group's products are intended for visualizing and detecting cellular abnormalities during the gastrointestinal and pulmonary endoscopic procedures, primarily in cancer patients. Net sales break down by activity as follows:

- sale of licenses (40.7%);

- sales of accessories (37.3%): mini-probes, software, etc.;

- sales of system (11.2%);

- services (10.8%).

Net sales are distributed geographically as follows: Europe/Middle East/Africa (15.5%), the United States and Canada (42.9%) and Asia (41.6%).

Number of employees: 65

Sales by Activity: Mauna Kea Technologies

Fiscal Period: December	2019	2020	2021	2022	2023
Endomeicroscopy	8.51M	7.24M	8.54M	8.11M	11.03M

See all business segments

Geographical breakdown of sales: Mauna Kea Technologies

Fiscal Period: December	2019	2020	2021	2022	2023
USA and Canada	-	-	-	-	4.49M
Asia	-	-	-	-	4.36M
EMEA (Europe, Middle East, Africa)	-	-	-	-	1.62M
EMEA & ROW	-	-	-	2.88M	-
Asia/Pacific	-	-	-	402K	-
United States & Canada	-	-	-	4.2M	-
Latin America	283K	-	-	-	-
Asia (Excluding China and Japan)	162K	137K	180K	-	-
Japan	41K	9K	-	-	-
China	2.36M	1.62M	1.38M	-	-
EMEA (Europe, Middle East, Africa) Excluding France	883K	782K	1.68M	-	-
United States of America	3.43M	3.59M	4.18M	-	-
France	268K	396K	277K	-	-

See all geographic segments

Managers: Mauna Kea Technologies

Director	Title	Age	Since
Sacha Loiseau CEO	Chief Executive Officer	-	03/10/2022
Côme de La Tour du Pin DFI	Director of Finance/CFO	-	12/06/2023
Nathalie Lecoq COO	Chief Operating Officer	-	-
Frédéric Banégas CTO	Chief Tech/Sci/R&D Officer	-	-
François Lacombe CTO	Chief Tech/Sci/R&D Officer	-	30/04/2000

See MAUNA KEA TECHNOLOGIES governance

Members of the board: Mauna Kea Technologies

Manager	Title	Age	Since
Sacha Loiseau CHM	Chairman	-	21/10/2018
Chris McFadden CHM	Chairman	-	12/06/2014
Molly O'Neill BRD	Director/Board Member	60	14/01/2018
Claire Biot BRD	Director/Board Member	-	22/07/2020
Jacquelien ten Dam BRD	Director/Board Member	-	31/12/2020

Composition of the Board of Directors

Shareholders: Mauna Kea Technologies

Name	Equities	%	Valuation
OFI Invest Asset Management SA 1.100 %	711,913	1.100 %	131 433 €
FUJIKURA LTD. 0.3277 %	212,000	0.3277 %	39 139 €
Pure Capital SA 0.0850 %	55,000	0.0850 %	10 154 €

List of MAUNA KEA TECHNOLOGIES shareholders

Company details: Mauna Kea Technologies

Mauna Kea Technologies SA

9, rue d'Enghien

75010, Paris

+33 1 48 24 03 45

http://www.maunakeatech.com

Medical Diagnostic & Testing Equipment

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi. ($)
MAUNA KEA TECHNOLOGIES	-2.29%	+1.55%	-59.04%	-76.79%	11.95M
SARTORIUS AG	+6.38%	+6.78%	-27.39%	-60.27%	14.26B
QUIDELORTHO CORPORATION	-4.71%	-3.56%	-41.26%	-71.18%	2.73B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	+0.80%	+2.89%	-17.42%	-	1.47B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+0.57%	-0.33%	-10.92%	+228.39%	1.41B
BIOTAGE AB	+0.98%	+3.25%	+35.97%	-34.70%	1.2B
CONTEC MEDICAL SYSTEMS CO.,LTD	+0.37%	-0.06%	-25.42%	-60.87%	888M
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	+2.10%	-6.29%	-28.04%	+31.42%	849M
REVENIO GROUP OYJ	-0.80%	+0.37%	+12.56%	-51.23%	773M
VAREX IMAGING CORPORATION	+2.02%	-4.15%	-21.08%	-44.24%	629M
Average	+0.51%	-0.32%	-18.20%	-15.50%	2.42B
Weighted average by Cap.	+3.27%	-1.48%	-22.77%	-38.19%